{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:25:29Z","timestamp":1792441529249,"version":"4.5.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/nrgastro.2016.107","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T05:24:02Z","timestamp":1468992242000},"page":"517-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":601,"title":["The bowel and beyond: the enteric nervous system in neurological disorders"],"prefix":"10.1038","volume":"13","author":[{"given":"Meenakshi","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"key":"BFnrgastro2016107_CR1","volume-title":"The Second Brain","author":"MD Gershon","year":"1998","unstructured":"Gershon, M. D. The Second Brain (Harper Collins, 1998)."},{"key":"BFnrgastro2016107_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","volume":"817","author":"JB Furness","year":"2014","unstructured":"Furness, J. B., Callaghan, B. P., Rivera, L. R. & Cho, H. J. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv. Exp. Med. Biol. 817, 39\u201371 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrgastro2016107_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2013.07.004","volume":"154","author":"H Clevers","year":"2013","unstructured":"Clevers, H. The intestinal crypt, a prototype stem cell compartment. Cell 154, 274\u2013284 (2013).","journal-title":"Cell"},{"key":"BFnrgastro2016107_CR4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799\u2013809 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016107_CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667\u2013685 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016107_CR6","volume-title":"The Autonomic Nervous System, Part 1 [1921]","author":"JN Langley","year":"2010","unstructured":"Langley, J. N. The Autonomic Nervous System, Part 1 [1921] (Cornell Univ. Library, 2010)."},{"key":"BFnrgastro2016107_CR7","volume-title":"The Enteric Nervous System","author":"JB Furness","year":"2006","unstructured":"Furness, J. B. The Enteric Nervous System (Blackwell Publishing, 2006)."},{"key":"BFnrgastro2016107_CR8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2010.06.002","volume":"33","author":"MD Gershon","year":"2010","unstructured":"Gershon, M. D. Developmental determinants of the independence and complexity of the enteric nervous system. Trends Neurosciences 33, 446\u2013456 (2010).","journal-title":"Trends Neurosciences"},{"key":"BFnrgastro2016107_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-0897-4_5","volume":"817","author":"P Forsythe","year":"2014","unstructured":"Forsythe, P., Bienenstock, J. & Kunze, W. A. Vagal pathways for microbiome\u2013brain\u2013gut axis communication. Adv. Exp. Med. Biol. 817, 115\u2013133 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrgastro2016107_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-3223(99)00304-2","volume":"47","author":"AJ Rush","year":"2000","unstructured":"Rush, A. J. et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry 47, 276\u2013286 (2000).","journal-title":"Biol. Psychiatry"},{"key":"BFnrgastro2016107_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0006-3223(99)00308-X","volume":"47","author":"MS George","year":"2000","unstructured":"George, M. S. et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47, 287\u2013295 (2000).","journal-title":"Biol. Psychiatry"},{"key":"BFnrgastro2016107_CR12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","volume":"17","author":"TR Sampson","year":"2015","unstructured":"Sampson, T. R. & Mazmanian, S. K. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17, 565\u2013576 (2015).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro2016107_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano, J. M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264\u2013276 (2015).","journal-title":"Cell"},{"key":"BFnrgastro2016107_CR14","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","volume":"34","author":"EA Mayer","year":"2014","unstructured":"Mayer, E. A., Knight, R., Mazmanian, S. K., Cryan, J. F. & Tillisch, K. Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 34, 15490\u201315496 (2014).","journal-title":"J. Neurosci."},{"key":"BFnrgastro2016107_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpedsurg.2015.10.021","volume":"51","author":"PK Tam","year":"2016","unstructured":"Tam, P. K. Hirschsprung's disease: a bridge for science and surgery. J. Pediatr. Surg. 51, 18\u201322 (2016).","journal-title":"J. Pediatr. Surg."},{"key":"BFnrgastro2016107_CR16","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1172\/JCI85003","volume":"125","author":"RO Heuckeroth","year":"2015","unstructured":"Heuckeroth, R. O. Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration. J. Clin. Invest. 125, 4323\u20134326 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016107_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmg.38.11.729","volume":"38","author":"J Amiel","year":"2001","unstructured":"Amiel, J. & Lyonnet, S. Hirschsprung disease, associated syndromes, and genetics: a review. J. Med. Genet. 38, 729\u2013739 (2001).","journal-title":"J. Med. Genet."},{"key":"BFnrgastro2016107_CR18","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJMra1410150","volume":"373","author":"C Bern","year":"2015","unstructured":"Bern, C. Chagas' disease. N. Engl. J. Med. 373, 1882 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016107_CR19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI76307","volume":"125","author":"M Avetisyan","year":"2015","unstructured":"Avetisyan, M., Schill, E. M. & Heuckeroth, R. O. Building a second brain in the bowel. J. Clin. Invest. 125, 899\u2013907 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016107_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer, L. & Reichmann, H. Pathogenesis of Parkinson disease \u2014 the gut\u2013brain axis and environmental factors. Nat. Rev. Neurol. 11, 625\u2013636 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrgastro2016107_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)15171-9","volume":"363","author":"SJ Collins","year":"2004","unstructured":"Collins, S. J., Lawson, V. A. & Masters, C. L. Transmissible spongiform encephalopathies. Lancet 363, 51\u201361 (2004).","journal-title":"Lancet"},{"key":"BFnrgastro2016107_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner, S. B. Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 47, 601\u2013623 (2013).","journal-title":"Annu. Rev. Genet."},{"key":"BFnrgastro2016107_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.0710824105","volume":"105","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi, A. Unraveling prion strains with cell biology and organic chemistry. Proc. Natl Acad. Sci. USA 105, 11\u201312 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016107_CR24","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1096\/fj.11-201772","volume":"26","author":"S Cronier","year":"2012","unstructured":"Cronier, S. et al. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J. 26, 3854\u20133861 (2012).","journal-title":"FASEB J."},{"key":"BFnrgastro2016107_CR25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2003.10.035","volume":"56","author":"S Ghosh","year":"2004","unstructured":"Ghosh, S. Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt\u2013Jakob disease. Adv. Drug Deliv. Rev. 56, 915\u2013920 (2004).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrgastro2016107_CR26","doi-asserted-by":"crossref","first-page":"e1002449","DOI":"10.1371\/journal.ppat.1002449","volume":"7","author":"P Kujala","year":"2011","unstructured":"Kujala, P. et al. Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog. 7, e1002449 (2011).","journal-title":"PLoS Pathog."},{"key":"BFnrgastro2016107_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00441-008-0583-y","volume":"332","author":"R Chiocchetti","year":"2008","unstructured":"Chiocchetti, R. et al. Anatomical evidence for ileal Peyer's patches innervation by enteric nervous system: a potential route for prion neuroinvasion? Cell Tissue Res. 332, 185\u2013194 (2008).","journal-title":"Cell Tissue Res."},{"key":"BFnrgastro2016107_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.autneu.2008.01.008","volume":"140","author":"V Albanese","year":"2008","unstructured":"Albanese, V. et al. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine. Auton. Neurosci. 140, 17\u201323 (2008).","journal-title":"Auton. Neurosci."},{"key":"BFnrgastro2016107_CR29","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/j.1365-2982.2012.01970.x","volume":"24","author":"GR Martin","year":"2012","unstructured":"Martin, G. R. et al. Endogenous cellular prion protein regulates contractility of the mouse ileum. Neurogastroenterol. Motil. 24, e412\u2013424 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2016107_CR30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1817-1745.159195","volume":"10","author":"A Posar","year":"2015","unstructured":"Posar, A., Resca, F. & Visconti, P. Autism according to diagnostic and statistical manual of mental disorders 5th edition: the need for further improvements. J. Pediatr. Neurosci. 10, 146\u2013148 (2015).","journal-title":"J. Pediatr. Neurosci."},{"key":"BFnrgastro2016107_CR31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1542\/peds.2013-3995","volume":"133","author":"BO McElhanon","year":"2014","unstructured":"McElhanon, B. O., McCracken, C., Karpen, S. & Sharp, W. G. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133, 872\u2013883 (2014).","journal-title":"Pediatrics"},{"key":"BFnrgastro2016107_CR32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamapediatrics.2013.2188","volume":"167","author":"N Halfon","year":"2013","unstructured":"Halfon, N. & Kuo, A. A. What DSM-5 could mean to children with autism and their families. JAMA Pediatr. 167, 608\u2013613 (2013).","journal-title":"JAMA Pediatr."},{"key":"BFnrgastro2016107_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","volume":"1380","author":"C Betancur","year":"2011","unstructured":"Betancur, C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 1380, 42\u201377 (2011).","journal-title":"Brain Res."},{"key":"BFnrgastro2016107_CR34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2012.04.009","volume":"74","author":"I Iossifov","year":"2012","unstructured":"Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285\u2013299 (2012).","journal-title":"Neuron"},{"key":"BFnrgastro2016107_CR35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11011","volume":"485","author":"BM Neale","year":"2012","unstructured":"Neale, B. M. et al. Patterns and rates of exonic De novo mutations in autism spectrum disorders. Nature 485, 242\u2013245 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2016107_CR36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","volume":"485","author":"BJ O'Roak","year":"2012","unstructured":"O'Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of De novo mutations. Nature 485, 246\u2013250 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2016107_CR37","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O'Roak","year":"2012","unstructured":"O'Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619\u20131622 (2012).","journal-title":"Science"},{"key":"BFnrgastro2016107_CR38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000083539","volume":"58","author":"TG Schulze","year":"2004","unstructured":"Schulze, T. G. & McMahon, F. J. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum. Hered. 58, 131\u2013138 (2004).","journal-title":"Hum. Hered."},{"key":"BFnrgastro2016107_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2014.06.017","volume":"158","author":"R Bernier","year":"2014","unstructured":"Bernier, R. et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158, 263\u2013276 (2014).","journal-title":"Cell"},{"key":"BFnrgastro2016107_CR40","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/emm.2013.32","volume":"45","author":"JD Sweatt","year":"2013","unstructured":"Sweatt, J. D. Pitt\u2013Hopkins syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. Exp. Mol. Med. 45, e21 (2013).","journal-title":"Exp. Mol. Med."},{"key":"BFnrgastro2016107_CR41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/aur.1467","volume":"8","author":"V Grubisic","year":"2015","unstructured":"Grubisic, V., Kennedy, A. J., Sweatt, J. D. & Parpura, V. Pitt\u2013Hopkins mouse model has altered particular gastrointestinal transits in vivo. Autism Res. 8, 629\u2013633 (2015).","journal-title":"Autism Res."},{"key":"BFnrgastro2016107_CR42","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10803-015-2646-8","volume":"46","author":"S Marler","year":"2016","unstructured":"Marler, S. et al. Brief report: whole blood serotonin levels and gastrointestinal symptoms in autism spectrum disorder. J. Autism Dev. Disord. 46, 1124\u20131130 (2016).","journal-title":"J. Autism Dev. Disord."},{"key":"BFnrgastro2016107_CR43","doi-asserted-by":"crossref","first-page":"G963","DOI":"10.1152\/ajpgi.90709.2008","volume":"296","author":"RB Matondo","year":"2009","unstructured":"Matondo, R. B. et al. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G963\u2013G968 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2016107_CR44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3181\/00379727-154-39702","volume":"154","author":"JJ Morrissey","year":"1977","unstructured":"Morrissey, J. J., Walker, M. N. & Lovenberg, W. The absence of tryptophan hydroxylase activity in blood platelets. Proc. Soc. Exp. Biol. Med. 154, 496\u2013499 (1977).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFnrgastro2016107_CR45","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/j.1471-4159.1993.tb03522.x","volume":"60","author":"KP Lesch","year":"1993","unstructured":"Lesch, K. P., Wolozin, B. L., Murphy, D. L. & Riederer, P. Primary structure of the human platelet serotonin (5-HT) uptake site: identity with the brain 5-HT transporter. J. Neurochem. 60, 2319\u20132322 (1993).","journal-title":"J. Neurochem."},{"key":"BFnrgastro2016107_CR46","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele, J. et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl Acad. Sci. USA 109, 5469\u20135474 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016107_CR47","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1172\/JCI84877","volume":"126","author":"KG Margolis","year":"2016","unstructured":"Margolis, K. G. et al. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J. Clin. Invest. 126, 2221\u20132235 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016107_CR48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley, R. L. et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J. Neurol. Neurosurg. Psychiatry 84, 637\u2013643 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrgastro2016107_CR49","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen, J. et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309, 1696\u20131703 (2013).","journal-title":"JAMA"},{"key":"BFnrgastro2016107_CR50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","volume":"36","author":"FI Roullet","year":"2013","unstructured":"Roullet, F. I., Lai, J. K. & Foster, J. A. In utero exposure to valproic acid and autism \u2014 a current review of clinical and animal studies. Neurotoxicol. Teratol. 36, 47\u201356 (2013).","journal-title":"Neurotoxicol. Teratol."},{"key":"BFnrgastro2016107_CR51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbi.2013.12.004","volume":"37","author":"CG de Theije","year":"2014","unstructured":"de Theije, C. G. et al. Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav. Immun. 37, 240\u2013247 (2014).","journal-title":"Brain Behav. Immun."},{"key":"BFnrgastro2016107_CR52","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2009.08.041","volume":"137","author":"JE Ghia","year":"2009","unstructured":"Ghia, J. E. et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137, 1649\u20131660 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016107_CR53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2982.2010.01479.x","volume":"22","author":"S Haub","year":"2010","unstructured":"Haub, S. et al. Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol. Motil. 22, 826\u2013e229 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2016107_CR54","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.90685.2008","volume":"296","author":"SC Bischoff","year":"2009","unstructured":"Bischoff, S. C. et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am. J. Physiol. Gastrointest Liver Physiol. 296, G685\u2013G695 (2009).","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"BFnrgastro2016107_CR55","first-page":"268","volume":"123","author":"MD Gershon","year":"2012","unstructured":"Gershon, M. D. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans. Am. Clin. Climatol. Assoc. 123, 268\u2013280; discussion 280 (2012).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"BFnrgastro2016107_CR56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","volume":"20","author":"MD Gershon","year":"2013","unstructured":"Gershon, M. D. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr. Opin. Endocrinol. Diabetes Obes. 20, 14\u201321 (2013).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"BFnrgastro2016107_CR57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1651-2227.2005.tb01904.x","volume":"94","author":"Z Liu","year":"2005","unstructured":"Liu, Z., Li, N. & Neu, J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 94, 386\u2013393 (2005).","journal-title":"Acta Paediatr."},{"key":"BFnrgastro2016107_CR58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1651-2227.1996.tb14220.x","volume":"85","author":"P D'Eufemia","year":"1996","unstructured":"D'Eufemia, P. et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 85, 1076\u20131079 (1996).","journal-title":"Acta Paediatr."},{"key":"BFnrgastro2016107_CR59","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s10803-007-0482-1","volume":"38","author":"MA Robertson","year":"2008","unstructured":"Robertson, M. A. et al. Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study. J. Autism Dev. Disord. 38, 1066\u20131071 (2008).","journal-title":"J. Autism Dev. Disord."},{"key":"BFnrgastro2016107_CR60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MPG.0b013e3181dcc4a5","volume":"51","author":"L de Magistris","year":"2010","unstructured":"de Magistris, L. et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51, 418\u2013424 (2010).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2016107_CR61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbi.2012.01.011","volume":"26","author":"NV Malkova","year":"2012","unstructured":"Malkova, N. V., Yu, C. Z., Hsiao, E. Y., Moore, M. J. & Patterson, P. H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 26, 607\u2013616 (2012).","journal-title":"Brain Behav. Immun."},{"key":"BFnrgastro2016107_CR62","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao, E. Y. et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451\u20131463 (2013).","journal-title":"Cell"},{"key":"BFnrgastro2016107_CR63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrgastro.2012.221","volume":"10","author":"M Neunlist","year":"2013","unstructured":"Neunlist, M. et al. The digestive neuronal\u2013glial\u2013epithelial unit: a new actor in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 10, 90\u2013100 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016107_CR64","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrgastro2016107_CR65","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman, S. J., Haupt, H. M., Yang, P. & Hamilton, S. R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 87, 848\u2013856 (1984).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016107_CR66","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.37.7.1253","volume":"37","author":"WJ Kupsky","year":"1987","unstructured":"Kupsky, W. J., Grimes, M. M., Sweeting, J., Bertsch, R. & Cote, L. J. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37, 1253\u20131255 (1987).","journal-title":"Neurology"},{"key":"BFnrgastro2016107_CR67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E. & Ikuta, F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol. (Berl.) 76, 217\u2013221 (1988).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BFnrgastro2016107_CR68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3940(89)90388-1","volume":"96","author":"K Wakabayashi","year":"1989","unstructured":"Wakabayashi, K., Takahashi, H., Ohama, E. & Ikuta, F. Tyrosine hydroxylase-immunoreactive intrinsic neurons in the Auerbach's and Meissner's plexuses of humans. Neurosci. Lett. 96, 259\u2013263 (1989).","journal-title":"Neurosci. Lett."},{"key":"BFnrgastro2016107_CR69","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1523\/JNEUROSCI.3982-03.2004","volume":"24","author":"ZS Li","year":"2004","unstructured":"Li, Z. S., Pham, T. D., Tamir, H., Chen, J. J. & Gershon, M. D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J. Neurosci. 24, 1330\u20131339 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrgastro2016107_CR70","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","volume":"26","author":"ZS Li","year":"2006","unstructured":"Li, Z. S., Schmauss, C., Cuenca, A., Ratcliffe, E. & Gershon, M. D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci. 26, 2798\u20132807 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrgastro2016107_CR71","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu, K. A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb. Perspect. Med. 1, a009316 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrgastro2016107_CR72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","volume":"207","author":"G Anderson","year":"2007","unstructured":"Anderson, G. et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp. Neurol. 207, 4\u201312 (2007).","journal-title":"Exp. Neurol."},{"key":"BFnrgastro2016107_CR73","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O. M. & Sudhof, T. C. \u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration. Cell 123, 383\u2013396 (2005).","journal-title":"Cell"},{"key":"BFnrgastro2016107_CR74","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal, C. H. & Chandra, S. S. Monomeric synucleins generate membrane curvature. J. Biol. Chem. 288, 1829\u20131840 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016107_CR75","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas, K. J. et al. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci. 34, 9364\u20139376 (2014).","journal-title":"J. Neurosci."},{"issue":"Suppl. 2","key":"BFnrgastro2016107_CR76","first-page":"II\/3","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak, H. & Braak, E. Pathoanatomy of Parkinson's disease. J. Neurol. 247 (Suppl. 2), II\/3\u2013II\/10 (2000).","journal-title":"J. Neurol."},{"key":"BFnrgastro2016107_CR77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JPD-150670","volume":"5","author":"C Preterre","year":"2015","unstructured":"Preterre, C. et al. Optimizing Western Blots for the detection of endogenous \u03b1-synuclein in the enteric nervous system. J. Parkinsons Dis. 5, 765\u2013772 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"BFnrgastro2016107_CR78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2015.07.005","volume":"602","author":"I Aldecoa","year":"2015","unstructured":"Aldecoa, I. et al. Alpha-synuclein immunoreactivity patterns in the enteric nervous system. Neurosci. Lett. 602, 145\u2013149 (2015).","journal-title":"Neurosci. Lett."},{"key":"BFnrgastro2016107_CR79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1871524915666150421114338","volume":"15","author":"F Miraglia","year":"2015","unstructured":"Miraglia, F., Betti, L., Palego, L. & Giannaccini, G. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Cent. Nerv. Syst. Agents Med. Chem. 15, 109\u2013116 (2015).","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"BFnrgastro2016107_CR80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","volume":"47","author":"PJ Hallett","year":"2012","unstructured":"Hallett, P. J., McLean, J. R., Kartunen, A., Langston, J. W. & Isacson, O. Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol. Dis. 47, 258\u2013267 (2012).","journal-title":"Neurobiol. Dis."},{"key":"BFnrgastro2016107_CR81","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","volume":"19","author":"L Wang","year":"2008","unstructured":"Wang, L., Fleming, S. M., Chesselet, M. F. & Tache, Y. Abnormal colonic motility in mice overexpressing human wild-type \u03b1-synuclein. Neuroreport 19, 873\u2013876 (2008).","journal-title":"Neuroreport"},{"key":"BFnrgastro2016107_CR82","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","volume":"24","author":"L Wang","year":"2012","unstructured":"Wang, L. et al. Mice overexpressing wild-type human \u03b1-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterol. Motil. 24, e425\u2013e436 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2016107_CR83","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"BFnrgastro2016107_CR84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger, R. et al. Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson's disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016107_CR85","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo, Y. M. et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated \u03b1-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 19, 1633\u20131650 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrgastro2016107_CR86","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1365-2982.2009.01368.x","volume":"22","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier, T. et al. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol. Motil. 22, e11\u2013e14 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2016107_CR87","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.25298","volume":"28","author":"A Gold","year":"2013","unstructured":"Gold, A., Turkalp, Z. T. & Munoz, D. G. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov. Disord. 28, 237\u2013240 (2013).","journal-title":"Mov. Disord."},{"key":"BFnrgastro2016107_CR88","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. JAMA 315, 2564-2575 (2016).","DOI":"10.1001\/jama.2016.5989"},{"key":"BFnrgastro2016107_CR89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton, D. et al. Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 127, 235\u2013241 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrgastro2016107_CR90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon, K. M. et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord. 27, 709\u2013715 (2012).","journal-title":"Mov. Disord."},{"key":"BFnrgastro2016107_CR91","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.0000000000001240","volume":"84","author":"NP Visanji","year":"2015","unstructured":"Visanji, N. P. et al. Colonic mucosal \u03b1-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 84, 609\u2013616 (2015).","journal-title":"Neurology"},{"key":"BFnrgastro2016107_CR92","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm, M. G., Danielsen, E. H., Hamilton-Dutoit, S. J. & Borghammer, P. Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann. Neurol. 79, 940\u2013949 (2016).","journal-title":"Ann. Neurol."},{"key":"BFnrgastro2016107_CR93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","volume":"346","author":"C Singaram","year":"1995","unstructured":"Singaram, C. et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 346, 861\u2013864 (1995).","journal-title":"Lancet"},{"key":"BFnrgastro2016107_CR94","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","volume":"124","author":"DM Annerino","year":"2012","unstructured":"Annerino, D. M. et al. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol. 124, 665\u2013680 (2012).","journal-title":"Acta Neuropathol."},{"key":"BFnrgastro2016107_CR95","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(81)90843-X","volume":"225","author":"VM Pickel","year":"1981","unstructured":"Pickel, V. M., Beckley, S. C., Joh, T. H. & Reis, D. J. Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res. 225, 373\u2013385 (1981).","journal-title":"Brain Res."},{"key":"BFnrgastro2016107_CR96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.pa.10.040170.001421","volume":"10","author":"N Weiner","year":"1970","unstructured":"Weiner, N. Regulation of norepinephrine biosynthesis. Annu. Rev. Pharmacol. 10, 273\u2013290 (1970).","journal-title":"Annu. Rev. Pharmacol."},{"key":"BFnrgastro2016107_CR97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","volume":"101","author":"E Braak","year":"2001","unstructured":"Braak, E. et al. alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol. 101, 195\u2013201 (2001).","journal-title":"Acta Neuropathol."},{"key":"BFnrgastro2016107_CR98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici, K., Rub, U., De Vos, R. A., Bohl, J. R. & Braak, H. Where does parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61, 413\u2013426 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrgastro2016107_CR99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak, H., Rub, U., Gai, W. P. & Del Tredici, K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517\u2013536 (2003).","journal-title":"J. Neural Transm."},{"key":"BFnrgastro2016107_CR100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2011.06.003","volume":"310","author":"K Del Tredici","year":"2011","unstructured":"Del Tredici, K. & Duda, J. E. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases. J. Neurol. Sci. 310, 100\u2013106 (2011).","journal-title":"J. Neurol. Sci."},{"key":"BFnrgastro2016107_CR101","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2008.02.074","volume":"153","author":"RJ Phillips","year":"2008","unstructured":"Phillips, R. J., Walter, G. C., Wilder, S. L., Baronowsky, E. A. & Powley, T. L. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience 153, 733\u2013750 (2008).","journal-title":"Neuroscience"},{"key":"BFnrgastro2016107_CR102","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L. & Richardson, R. J. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346\u20131350 (1998).","journal-title":"Neurology"},{"key":"BFnrgastro2016107_CR103","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo, F. et al. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5, e8762 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016107_CR104","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo, F. et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci. Rep. 2, 898 (2012).","journal-title":"Sci. Rep."},{"key":"BFnrgastro2016107_CR105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy, A. et al. Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections. EMBO Mol. Med. 5, 1051\u20131059 (2013).","journal-title":"EMBO Mol. Med."},{"key":"BFnrgastro2016107_CR106","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist, S. et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805\u2013820 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrgastro2016107_CR107","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson, E. et al. Vagotomy and subsequent risk of Parkinson's disease. Ann. Neurol. 78, 522\u2013529 (2015).","journal-title":"Ann. Neurol."},{"key":"BFnrgastro2016107_CR108","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/ana.24531","volume":"78","author":"OB Tysnes","year":"2015","unstructured":"Tysnes, O. B. et al. Does vagotomy reduce the risk of Parkinson's disease? Ann. Neurol. 78, 1011\u20131012 (2015).","journal-title":"Ann. Neurol."},{"key":"BFnrgastro2016107_CR109","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger, K. A. A critical evaluation of current staging of \u03b1-synuclein pathology in Lewy body disorders. Biochim. Biophys. Acta 1792, 730\u2013740 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrgastro2016107_CR110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M. & Pearce, R. K. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of \u03b1-synuclein staging. Neuropathol. Appl. Neurobiol. 34, 284\u2013295 (2008).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrgastro2016107_CR111","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury, A. E. et al. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model. Mov. Disord. 25, 2508\u20132515 (2010).","journal-title":"Mov. Disord."},{"key":"BFnrgastro2016107_CR112","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.3233\/JAD-2012-129028","volume":"33","author":"K Ubhi","year":"2013","unstructured":"Ubhi, K. & Masliah, E. Alzheimer's disease: recent advances and future perspectives. J. Alzheimers Dis. 33, S185\u2013S194 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrgastro2016107_CR113","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11064-005-6962-9","volume":"30","author":"R Schliebs","year":"2005","unstructured":"Schliebs, R. Basal forebrain cholinergic dysfunction in Alzheimer's disease \u2014 interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem. Res. 30, 895\u2013908 (2005).","journal-title":"Neurochem. Res."},{"key":"BFnrgastro2016107_CR114","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ana.410300509","volume":"30","author":"H Arai","year":"1991","unstructured":"Arai, H. et al. Expression patterns of beta-amyloid precursor protein (\u03b2-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann. Neurol. 30, 686\u2013693 (1991).","journal-title":"Ann. Neurol."},{"key":"BFnrgastro2016107_CR115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11481-011-9327-y","volume":"7","author":"KL Puig","year":"2012","unstructured":"Puig, K. L., Swigost, A. J., Zhou, X., Sens, M. A. & Combs, C. K. Amyloid precursor protein expression modulates intestine immune phenotype. J. Neuroimmune Pharmacol. 7, 215\u2013230 (2012).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"BFnrgastro2016107_CR116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JAD-120511","volume":"36","author":"S Semar","year":"2013","unstructured":"Semar, S. et al. Changes of the enteric nervous system in amyloid-\u03b2 protein precursor transgenic mice correlate with disease progression. J. Alzheimers Dis. 36, 7\u201320 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrgastro2016107_CR117","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3233\/JAD-142259","volume":"44","author":"KL Puig","year":"2015","unstructured":"Puig, K. L. et al. Overexpression of mutant amyloid-\u03b2 protein precursor and presenilin 1 modulates enteric nervous system. J. Alzheimers Dis. 44, 1263\u20131278 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrgastro2016107_CR118","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/341226a0","volume":"341","author":"CL Joachim","year":"1989","unstructured":"Joachim, C. L., Mori, H. & Selkoe, D. J. Amyloid \u03b2-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341, 226\u2013230 (1989).","journal-title":"Nature"},{"key":"BFnrgastro2016107_CR119","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0022-3468(93)90688-H","volume":"28","author":"E Deguchi","year":"1993","unstructured":"Deguchi, E., Iwai, N., Goto, Y., Yanagihara, J. & Fushiki, S. An immunohistochemical study of neurofilament and microtubule-associated Tau protein in the enteric innervation in Hirschsprung's disease. J. Pediatr. Surg. 28, 886\u2013890 (1993).","journal-title":"J. Pediatr. Surg."},{"key":"BFnrgastro2016107_CR120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0046-8177(93)90092-U","volume":"24","author":"PK Tam","year":"1993","unstructured":"Tam, P. K. & Owen, G. An immunohistochemical study of neuronal microtubule-associated proteins in Hirschsprung's disease. Hum. Pathol. 24, 424\u2013431 (1993).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2016107_CR121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.expneurol.2009.07.025","volume":"220","author":"RJ Phillips","year":"2009","unstructured":"Phillips, R. J., Walter, G. C., Ringer, B. E., Higgs, K. M. & Powley, T. L. Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat. Exp. Neurol. 220, 109\u2013119 (2009).","journal-title":"Exp. Neurol."},{"key":"BFnrgastro2016107_CR122","first-page":"10","volume":"6","author":"WR Shankle","year":"1993","unstructured":"Shankle, W. R. et al. Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease. Mod. Pathol. 6, 10\u201314 (1993).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016107_CR123","doi-asserted-by":"publisher","unstructured":"Jovicic, A., Paul, J. W. 3rd & Gitler, A. D. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurochem. http:\/\/dx.doi.org\/10.1111\/jnc.13642 (2016).","DOI":"10.1111\/jnc.13642"},{"key":"BFnrgastro2016107_CR124","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00415-009-5069-7","volume":"256","author":"F Geser","year":"2009","unstructured":"Geser, F., Martinez-Lage, M., Kwong, L. K., Lee, V. M. & Trojanowski, J. Q. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J. Neurol. 256, 1205\u20131214 (2009).","journal-title":"J. Neurol."},{"key":"BFnrgastro2016107_CR125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi, E. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572\u2013574 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016107_CR126","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668\u20131672 (2008).","journal-title":"Science"},{"key":"BFnrgastro2016107_CR127","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1212\/WNL.0b013e3182735d36","volume":"79","author":"A Chio","year":"2012","unstructured":"Chio, A. et al. Extensive genetics of ALS: a population-based study in Italy. Neurology 79, 1983\u20131989 (2012).","journal-title":"Neurology"},{"key":"BFnrgastro2016107_CR128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"BFnrgastro2016107_CR129","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. & Baloh, R. H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809\u201318814 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016107_CR130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.04.003","volume":"1460","author":"Y Guo","year":"2012","unstructured":"Guo, Y. et al. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 1460, 88\u201395 (2012).","journal-title":"Brain Res."},{"key":"BFnrgastro2016107_CR131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/iep.12006","volume":"94","author":"MA Esmaeili","year":"2013","unstructured":"Esmaeili, M. A., Panahi, M., Yadav, S., Hennings, L. & Kiaei, M. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int. J. Exp. Pathol. 94, 56\u201364 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"BFnrgastro2016107_CR132","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-9-24","volume":"9","author":"S Herdewyn","year":"2014","unstructured":"Herdewyn, S. et al. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol. Neurodegener. 9, 24 (2014).","journal-title":"Mol. Neurodegener."},{"key":"BFnrgastro2016107_CR133","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2013.10.013","volume":"1584","author":"T Hatzipetros","year":"2014","unstructured":"Hatzipetros, T. et al. C57BL\/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 1584, 59\u201372 (2014).","journal-title":"Brain Res."},{"key":"BFnrgastro2016107_CR134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","volume":"577","author":"SJ Kaur","year":"2016","unstructured":"Kaur, S. J., McKeown, S. R. & Rashid, S. Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene 577, 109\u2013118 (2016).","journal-title":"Gene"},{"key":"BFnrgastro2016107_CR135","doi-asserted-by":"crossref","first-page":"e12356","DOI":"10.14814\/phy2.12356","volume":"3","author":"S Wu","year":"2015","unstructured":"Wu, S., Yi, J., Zhang, Y. G., Zhou, J. & Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3, e12356 (2015).","journal-title":"Physiol. Rep."},{"key":"BFnrgastro2016107_CR136","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.gastro.2012.05.007","volume":"143","author":"ER Gross","year":"2012","unstructured":"Gross, E. R., Gershon, M. D., Margolis, K. G., Gertsberg, Z. V. & Cowles, R. A. Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology 143, 408\u2013417.e2 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016107_CR137","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2982.2011.01794.x","volume":"23","author":"G Natale","year":"2011","unstructured":"Natale, G., Pasquali, L., Paparelli, A. & Fornai, F. Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol. Motil. 23, 1056\u20131065 (2011).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2016107_CR138","doi-asserted-by":"crossref","first-page":"a006833","DOI":"10.1101\/cshperspect.a006833","volume":"3","author":"DW Colby","year":"2011","unstructured":"Colby, D. W. & Prusiner, S. B. Prions. Cold Spring Harb. Perspect. Biol. 3, a006833 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"BFnrgastro2016107_CR139","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acs.chemrestox.6b00034","volume":"29","author":"A Pinkas","year":"2016","unstructured":"Pinkas, A. & Aschner, M. Advanced glycation end-products and their receptors: related pathologies, recent therapeutic strategies, and a potential model for future neurodegeneration studies. Chem. Res. Toxicol. 29, 707\u2013714 (2016).","journal-title":"Chem. Res. Toxicol."},{"key":"BFnrgastro2016107_CR140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","volume":"10","author":"H Deng","year":"2014","unstructured":"Deng, H., Gao, K. & Jankovic, J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 10, 337\u2013348 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrgastro2016107_CR141","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1038\/ncomms10465","volume":"7","author":"A Sharma","year":"2016","unstructured":"Sharma, A. et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 7, 10465 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrgastro2016107_CR142","doi-asserted-by":"publisher","unstructured":"Parakh, S. & Atkin, J. D. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. http:\/\/dx.doi.org\/10.1016\/j.brainres.2016.04.010 (2016).","DOI":"10.1016\/j.brainres.2016.04.010"},{"key":"BFnrgastro2016107_CR143","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A. et al. Varicella zoster virus infection. Nat. Rev. Dis. Primers 1, 15016 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"BFnrgastro2016107_CR144","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/cid\/civ320","volume":"61","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A., Chen, J. & Gershon, M. D. Use of saliva to identify varicella zoster virus infection of the gut. Clin. Infect. Dis. 61, 536\u2013544 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2016107_CR145","first-page":"17","volume":"123","author":"AA Gershon","year":"2012","unstructured":"Gershon, A. A. et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans. Am. Clin. Climatol. Assoc. 123, 17\u201333; discussion 33\u201335 (2012).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"BFnrgastro2016107_CR146","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jpedsurg.2005.12.060","volume":"41","author":"S Holland-Cunz","year":"2006","unstructured":"Holland-Cunz, S. et al. Acquired intestinal aganglionosis after a lytic infection with varicella-zoster virus. J. Pediatr. Surg. 41, e29\u2013e31 (2006).","journal-title":"J. Pediatr. Surg."},{"key":"BFnrgastro2016107_CR147","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jcv.2014.09.012","volume":"61","author":"MJ Levin","year":"2014","unstructured":"Levin, M. J. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. J. Clin. Virol. 61, 487\u2013495 (2014).","journal-title":"J. Clin. Virol."},{"key":"BFnrgastro2016107_CR148","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jemermed.2009.02.010","volume":"39","author":"DA Edelman","year":"2009","unstructured":"Edelman, D. A. et al. Ogilvie syndrome and herpes zoster: case report and review of the literature. J. Emerg. Med. 39, 696\u2013700 (2009).","journal-title":"J. Emerg. Med."},{"key":"BFnrgastro2016107_CR149","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/527420","volume":"197","author":"SK Mehta","year":"2008","unstructured":"Mehta, S. K. et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J. Infect. Dis. 197, 654\u2013657 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2016107_CR150","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jinf.2015.04.015","volume":"71","author":"CJ Duncan","year":"2015","unstructured":"Duncan, C. J. & Hambleton, S. Varicella zoster virus immunity: a primer. J. Infect. 71, S47\u2013S53 (2015).","journal-title":"J. Infect."},{"key":"BFnrgastro2016107_CR151","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12879-015-1262-8","volume":"15","author":"BH Johnson","year":"2015","unstructured":"Johnson, B. H. et al. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect. Dis. 15, 502 (2015).","journal-title":"BMC Infect. Dis."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:55:52Z","timestamp":1718690152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":151,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFnrgastro2016107"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.107","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"assertion":[{"value":"20 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}